Celldex Therapeutics CLDX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Celldex Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Celldex Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Celldex Therapeutics's operating margin?
- Celldex Therapeutics (CLDX) reported operating margin of -35,688.5% in Q1 2026.
- How has Celldex Therapeutics's operating margin changed year-over-year?
- Celldex Therapeutics's operating margin decreased by 1142.0% year-over-year, from -2,873.5% to -35,688.5%.
- What is the long-term trend for Celldex Therapeutics's operating margin?
- Over 5 years (2020 to 2025), Celldex Therapeutics's operating margin has grown at a 85.2% compound annual growth rate (CAGR), from -854.1% to -18,587.7%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.